135 related articles for article (PubMed ID: 29403909)
1. Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLC-MS/MS.
Bhatt NM; Chavada VD; Patel DP; Sharma P; Sanyal M; Shrivastav PS
J Pharm Anal; 2015 Feb; 5(1):1-11. PubMed ID: 29403909
[TBL] [Abstract][Full Text] [Related]
2. UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4'-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers.
Patel DP; Sharma P; Sanyal M; Singhal P; Shrivastav PS
Biomed Chromatogr; 2013 Aug; 27(8):974-86. PubMed ID: 23483571
[TBL] [Abstract][Full Text] [Related]
3. Determination of lercanidipine in human plasma by an improved UPLC-MS/MS method for a bioequivalence study.
Chaudhary DV; Patel DP; Shah PA; Shah JV; Sanyal M; Shrivastav PS
J Pharm Anal; 2016 Apr; 6(2):87-94. PubMed ID: 29403967
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography - tandem mass spectrometry for the simultaneous quantitation of glipizide, cilostazol and its active metabolite 3, 4-dehydro-cilostazol in rat plasma: application for a pharmacokinetic study.
Satheeshmanikandan TR; Sridhar V; Kanthikiran VV; Swaroopkumar VV; Mukkanti K
Arzneimittelforschung; 2012 Sep; 62(9):425-32. PubMed ID: 22821721
[TBL] [Abstract][Full Text] [Related]
5. A new simple method for quantification of cilostazol and its active metabolite in human plasma by LC-MS/MS: Application to pharmacokinetics of cilostazol associated with CYP genotypes in healthy Chinese population.
Shen Y; Jiang B; Hu X; Chen J; Xu Y; Ruan Z; Yang D; Lou H
Biomed Chromatogr; 2021 Oct; 35(10):e5150. PubMed ID: 33894005
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of nateglinide, cilostazol and its active metabolite 3,4-dehydro-cilostazol in Wistar rat plasma and its application to pharmacokinetic study.
Varanasi KK; Sridhar V; Potharaju S; Shraddha R; Sivakumar SP; Sabapathi SK; Satheeshmanikandan TR; Kumar VV
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 865(1-2):91-8. PubMed ID: 18342586
[TBL] [Abstract][Full Text] [Related]
7. A novel, sensitive and selective method of UPLC/MS-MS for rapid simultaneous determination of midodrine and its active metabolite desglymidodrine in human plasma: Application to support bioequivalence study in healthy human volunteers.
Patel DP; Nair S; Suhagia BN; Patel BM
J Pharm Biomed Anal; 2016 Nov; 131():355-363. PubMed ID: 27639073
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantification of atenolol and chlorthalidone in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
Shah JV; Patel DP; Shah PA; Sanyal M; Shrivastav PS
Biomed Chromatogr; 2016 Feb; 30(2):208-16. PubMed ID: 26096961
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous analysis of glucocorticosteroid fluticasone propionate and its metabolite fluticasone propionate 17β-carboxylic acid in human plasma by UPLC-MS/MS at sub pg/mL level.
Nair SG; Patel DP; Sanyal M; Singhal P; Shrivastav PS
J Pharm Biomed Anal; 2017 Feb; 135():1-7. PubMed ID: 27987390
[TBL] [Abstract][Full Text] [Related]
10. Effect of Baicalein on the Pharmacokinetics of Cilostazol and Its Two Metabolites in Rat Plasma Using UPLC-MS/MS Method.
Weng Q; Chen C; Xiong J; Liu YN; Pan X; Cui J; Cai JP; Xu RA
Front Pharmacol; 2022; 13():888054. PubMed ID: 35571101
[TBL] [Abstract][Full Text] [Related]
11. SPE-UPLC-MS/MS assay for determination of letrozole in human plasma and its application to bioequivalence study in healthy postmenopausal Indian women.
Vanol PG; Singhal P; Shah PA; Shah JV; Shrivastav PS; Sanyal M
J Pharm Anal; 2016 Aug; 6(4):276-281. PubMed ID: 29403993
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous analysis of oxybutynin and its active metabolite N-desethyl oxybutynin in human plasma by stable isotope dilution LC-MS/MS to support a bioequivalence study.
Sharma P; Patel DP; Sanyal M; Berawala H; Guttikar S; Shrivastav PS
J Pharm Biomed Anal; 2013 Oct; 84():244-55. PubMed ID: 23867086
[TBL] [Abstract][Full Text] [Related]
13. Application of a rapid and selective method for the simultaneous determination of protease inhibitors, lopinavir and ritonavir in human plasma by UPLC-ESI-MS/MS for bioequivalence study in Indian subjects.
Yadav M; Rao R; Kurani H; Singhal P; Goswami S; Shrivastav PS
J Pharm Biomed Anal; 2009 May; 49(4):1115-22. PubMed ID: 19282124
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of prodrug oseltamivir and its metabolite oseltamivir carboxylate in human plasma by LC-MS/MS to support a bioequivalence study.
Gupta A; Guttikar S; Shrivastav PS; Sanyal M
J Pharm Anal; 2013 Jun; 3(3):149-160. PubMed ID: 29403810
[TBL] [Abstract][Full Text] [Related]
15. Determination of terbinafine in human plasma using UPLC-MS/MS: Application to a bioequivalence study in healthy subjects.
Bhadoriya A; Shah PA; Shrivastav PS; Bharwad KD; Singhal P
Biomed Chromatogr; 2019 Aug; 33(8):e4543. PubMed ID: 30933360
[TBL] [Abstract][Full Text] [Related]
16. Validated high performance liquid chromatographic method for simultaneous determination of rosiglitazone, cilostazol, and 3,4-dehydro-cilostazol in rat plasma and its application to pharmacokinetics.
Varanasi VS; Veeraraghavan S; Potharaju S; Thappali RS; Raghavan R; Vakkalanka VS
Arzneimittelforschung; 2008; 58(6):288-96. PubMed ID: 18677971
[TBL] [Abstract][Full Text] [Related]
17. Development of an SPE-LC-MS/MS method for simultaneous quantification of bosentan and its active metabolite hydroxybosentan in human plasma to support a bioequivalence study.
Parekh JM; Shah DK; Sanyal M; Yadav M; Shrivastav PS
J Pharm Biomed Anal; 2012 Nov; 70():462-70. PubMed ID: 22789899
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of cilostazol and its primary metabolite 3,4-dehydrocilostazol in human plasma by rapid liquid chromatography/tandem mass spectrometry.
Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Shrivasthava W; Datla PV; Yerramilli A
Anal Bioanal Chem; 2006 Feb; 384(3):780-90. PubMed ID: 16440196
[TBL] [Abstract][Full Text] [Related]
19. Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry.
Upadhyay V; Trivedi V; Shah G; Yadav M; Shrivastav PS
J Pharm Anal; 2014 Jun; 4(3):205-216. PubMed ID: 29403884
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography--tandem mass spectrometry method for simultaneous determination of albendazole and albendazole sulfoxide in human plasma for bioequivalence studies.
Rathod DM; Patel KR; Mistri HN; Jangid AG; Shrivastav PS; Sanyal M
J Pharm Anal; 2016 Aug; 6(4):226-234. PubMed ID: 29403987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
